Sanofi, EU Medicines Agencies Flag Acquired Hemophilia Link To Clopidogrel
This article was originally published in The Pink Sheet Daily
Executive Summary
Although only 12 cases have been reported to the company, extensive use of the anti-platelet drug and shortfalls in adverse event reporting systems mean the number could rise.
You may also be interested in...
Evidence Growing That Drug Counterfeiters Are Targeting Generics In The EU
Counterfeit omeprazole has been found for the third time in Germany, suggesting that the generics sector must raise its game to combat this phenomenon.
Sanofi Set To Seek $442 Million From Apotex For Plavix Infringement
District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.
Plavix Sales Plummet With Generic Entry
Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.